[L-DOPA therapy of parkinsonism].
D000818:Animals; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004298:Dopamine / Q000652:urine; D005260:Female; D006801:Humans; D008297:Male; D009461:Neurologic Manifestations; D010300:Parkinson Disease / Q000188:drug therapy*; D051381:Rats; D013997:Time Factors
D004295:Dihydroxyphenylalanine; D004298:Dopamine
L-DOPA-behandling ved parkinsonisme.